MassBio

We are 1 week away from the #StateofPossible26 Conference! Our speaker lineup includes Governor Healey, Noubar Afeyan, Christopher Viehbacher, Jigar Raythatha, biotech leaders, patient advocates, and more. Secure your spot today! massbio.org/events/state-o… #PatientDriven

𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐍𝐨𝐰: @MassBio State of Possible Conference is Thursday, March 26th at the Boston Omni Seaport. It is the premier event of the year for the Massachusetts life sciences industry BiotechTV will be there. See you next week! Register: massbio.org/events/state-o…

More details and apply: massbio.org/termeer-ascend/ #TermeerAscend #BiotechLeadership

You're not waiting for permission to lead. You're already doing it. Termeer Ascend gives senior biotech leaders the skills, mentorship, and network to take the next step. Watch the Q&A to learn more: youtu.be/0hT9Ph54Z5Q?si…

#MassBioMember @CollegiumPharma is proud to support the Boston Legacy FC as a founding partner and to help bring a new era of professional women’s soccer to Boston. Read more: massbio.org/news/recent-ne…

Their answers will appear throughout the State of Possible Conference on March 26 as a series of short vignettes woven into the day's program. Join us to hear it for yourself: massbio.org/events/state-o… #biotech #stateofpossible26 #patientdriven #leadership #breakthroughs

🎥 We sat down with 20 leaders and scientists from across the Massachusetts biopharma ecosystem and asked them a series of questions that boiled down to two: What does it take to get to a breakthrough? What's it like to be behind a breakthrough?

These are just two of the observations you can expect to hear from the conversation our biotech CEOs will have at this year's State of Possible Conference on March 26. Get a preview in this blog: massbio.org/news/recent-ne… Register: massbio.org/events/state-o…

"Most companies fail not because of science but because of people." "Move too slowly and you lose momentum, talent, and opportunity." Sound familiar? Or maybe surprising? #StateofPossible26

Massachusetts is home to a unique ecosystem of research institutions, venture capital and entrepreneurs, and as @JMaraganore said at our 2026 Policy Leadership Breakfast, this combination can produce striking medical innovations. Watch more: mbvision.massbio.org/channel/though… #PatientDriven

Our next #CEOFounderLink event on April 13 explores Building Great Companies by Building Great Leaders: Culture as Strategy. Apply to the Link to attend for learning, networking, and growth! massbio.org/innovation/ceo…

Massachusetts has some of the brightest minds in the world working on this: scientists, physicians, patient advocates, & policymakers who refuse to treat women's health as an afterthought. We're proud to elevate their work today and throughout the year.

And we've made progress. FDA-approved therapies are slowing Alzheimer's progression. New blood biomarker tests are leading to earlier diagnosis. The biopharma pipeline is increasingly targeting conditions that affect women. The advances are real. So is the work that remains.

For the last 3 years, we've brought legislators, researchers, and advocates together at the Massachusetts State House around a simple premise: women's health is a scientific and economic imperative, and it deserves to be treated like one. #InternationalWomensDay2026

Proving a medicine works is hard. Proving it's worth the price is harder. If you're thinking about value, access, pricing, or the industry's relationship with the public it serves, this is a session worth being in the room for on 3/26. Read the blog: massbio.org/news/recent-ne…

Video clip via TED. Watch the full talk: ted.com/talks/anna_gre… @AnnaGreka

What if treating one disease could unlock treatments for dozens more? Physician-scientist Anna Greka takes this further at the #StateofPossible26 Conference on March 26. Register: massbio.org/events/state-o…

Servier's Anne Angiolillo shared her perspective on clinical trial research in a conversation moderated by Samantha Gilman at this year's @MassBio Rare Disease Forum. We're inspired by the insights shared and remain committed to advancing support for the rare disease community.

A strong perspective from @MassBio on what makes Kendall Square — and Massachusetts — a global engine for innovation. @NoubarAfeyan will continue the conversation with @MassGovernor Healey at #StateofPossible on March 26. Learn more: massbio.org/news/recent-ne…

Peter Marks, former Director of FDA and current SVP at Eli Lilly, joined MassBio’s #RareDiseaseDay26 Forum last week to share his vision for scaling gene therapy to reach the thousands of patients who need it most: massbio.org/news/recent-ne…